Daily BriefsThematic (Sector/Industry)

Daily Brief Thematic (Sector/Industry): Ohayo Japan | Markets Wary of Conflict; Toyota and Idemitsu Partner on Solid-State Batteries and more

In today’s briefing:

  • Ohayo Japan | Markets Wary of Conflict; Toyota and Idemitsu Partner on Solid-State Batteries
  • What Is Holding Back China Consumers’ Potential?
  • GLP-1 Drugs – Are They Dessert or Time Bomb to Your Portfolio?
  • China Weekly Economic Wrap 10-15-2023


Ohayo Japan | Markets Wary of Conflict; Toyota and Idemitsu Partner on Solid-State Batteries

By Mark Chadwick

  • Overseas: U.S. equities declined on Friday due to escalating conflict in the Middle East, leading to higher oil prices and a flight to safety assets like bonds and gold.
  • Today: Lawson increases dividend due to strong domestic business. Daikin eyes European heat pump market. Mazda targets EV expansion in the US.
  • JapanX: Toyota and Idemitsu Partner to Revolutionize EVs with Solid-State Batteries

What Is Holding Back China Consumers’ Potential?

By Eric Chen

  • The vast majority of under-educated Chinese in less-developed regions are largely irrelevant to the China consumer market as investors and analysts know it.
  • That is why that simple benchmarking with developed markets on per capita basis almost always results in forecasts that prove too optimistic in hindsight.
  • They risk being further left behind as technology advancements and economic transformation may block the path for their income growth and hence derail consumption upgrade.

GLP-1 Drugs – Are They Dessert or Time Bomb to Your Portfolio?

By Xinyao (Criss) Wang

  • The potential/market size of GLP-1 drugs is much greater-than-expected. Indication expansion could easily generate big returns. Investment strategy for GLP-1 drugs should be long-term, which is expected to bring alpha.
  • Supply-Demand relationship of entire market would change due to popularization of GLP-1 drugs.This is not only for healthcare, but also cause a change in the investment logic of other industries.
  • It’s recommended to re-examine stock positions in portfolio. Because each indication expansion of GLP-1 drugs would mean a decrease in demand in another field, leading to potential stock price plummet.

China Weekly Economic Wrap 10-15-2023

By Fern Wang

  • Country Garden default warning, Huijin’s Big 4 investments, Regulators reined in offshore new brokerage accounts, PBOC roles fine-tuned
  • China tightened rules on security lending to boost confidence of investors
  • September China Import/Export data continued to decline and Government bond issuance continued to support ASF growth

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars